The ACMG have released a statement that cautions potential customers against the limits of direct-to-consumer testing after approval from the FDA last week
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
Engineering immune cells to hunt and destroy cancer cells might be able to help ALL patients live much longer than standard therapies
We’ve all been told that next generation sequencing is revolutionising healthcare. But how is it actually being applied, today?
Thermo Fisher Scientific announce a new microarray-based assay for ‘all-in-one’ research designed to detect 6,000 genomic variants across ethnic groups
A new study suggests that while more low-risk women are being screened, BRCA testing may well be underused for high-risk people
Study examines a “foraging gene” humans share in common with flies
Research has shown that DNA-based prenatal blood tests can be offered appropriately and effectively to all women